Invention Grant
- Patent Title: HPIV3 RNA vaccines
-
Application No.: US16368270Application Date: 2019-03-28
-
Publication No.: US10702599B2Publication Date: 2020-07-07
- Inventor: Giuseppe Ciaramella , Sunny Himansu
- Applicant: ModernaTX, Inc.
- Applicant Address: US MA Cambridge
- Assignee: ModernaTX, Inc.
- Current Assignee: ModernaTX, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/155
- IPC: A61K39/155 ; A61K39/12 ; A61P11/00 ; C07K16/10 ; A61K39/00
Abstract:
The disclosure relates to respiratory virus ribonucleic acid (RNA) vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Public/Granted literature
- US20190240317A1 HPIV3 RNA VACCINES Public/Granted day:2019-08-08
Information query
